Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virusinduced demyelinating disease of the human brain, Clin Microbiol Rev, vol.25, pp.471-506, 2012. ,
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section, Neurology, vol.80, pp.1430-1438, 2013. ,
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies, J Allergy Clin Immunol, vol.140, pp.1388-1393, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01783653
International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity, J Clin Immunol, vol.38, pp.96-128, 2018. ,
Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis, Immunity, vol.33, pp.400-411, 2010. ,
Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.62, pp.986-94, 2016. ,
Progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia: a case report and review of reported cases, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.31, pp.20-22, 2000. ,
Long-term remission in progressive multifocal leukoencephalopathy caused by idiopathic CD4+ T lymphocytopenia: a case report, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.42, pp.53-59, 2006. ,
Treatment of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia, J Antimicrob Chemother, vol.65, pp.2489-92, 2010. ,
Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation, Clin Immunol Orlando Fla, vol.178, pp.39-44, 2017. ,
X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy, Arch Neurol, vol.64, pp.273-279, 2007. ,
Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease, J Clin Immunol, vol.35, pp.112-120, 2015. ,
Evaluation of RAG1 mutations in an, Clin Immunol Orlando Fla, vol.179, pp.1-7, 2017. ,
Genetic diagnosis using whole exome sequencing in common variable immunodeficiency, Front Immunol, vol.7, p.220, 2016. ,
A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection, J Clin Invest, vol.115, pp.3291-3300, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00020065
T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient, Blood, vol.88, pp.1708-1725, 1996. ,
Anti-JC virus (JCV) antibody prevalence in the JCV epidemiology in MS (JEMS) trial, Eur J Neurol, vol.21, pp.299-304, 2014. ,
Risk of natalizumab-associated progressive multifocal leukoencephalopathy, N Engl J Med, vol.366, pp.1870-80, 2012. ,
Incidence of progressive multifocal leukoencephalopathy in patients without HIV, Neurology, vol.75, pp.1326-1358, 2010. ,
AIDS-and non-AIDS-related PML association with distinct p53 polymorphism, Neurology, vol.54, pp.743-749, 2000. ,
Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study, J Infect Dis, vol.199, pp.77-83, 2009. ,
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients, Br J Haematol, vol.155, pp.498-508, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00820062
Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF-? mAbs, J Allergy Clin Immunol, vol.128, pp.847-53, 2011. ,
Classifying PML risk with disease modifying therapies, Mult Scler Relat Disord, vol.12, pp.59-63, 2017. ,
Re: rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials, J Natl Cancer Inst, vol.101, pp.1289-1290, 2009. ,
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project, Blood, vol.113, pp.4834-4874, 2009. ,
Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies, Arthritis Rheum, vol.64, pp.3043-51, 2012. ,
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event, J Neuro-Oncol, vol.24, pp.323-354, 2018. ,
Infliximab and the risk of latent viruses reactivation in active Crohn's disease, Inflamm Bowel Dis, vol.13, pp.896-902, 2007. ,
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients, Semin Arthritis Rheum, vol.47, pp.288-94, 2017. ,
Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS), Pharmacoepidemiol Drug Saf, vol.21, pp.1216-1236, 2012. ,
Stratification and monitoring of natalizumabassociated progressive multifocal leukoencephalopathy risk: recommendations from an expert group, J Neurol Neurosurg Psychiatry, vol.87, pp.117-142, 2016. ,
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification, J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol, vol.7, pp.665-72, 2012. ,
JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.53, pp.711-716, 2011. ,
Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis, Eur J Neurol, vol.19, pp.1060-1069, 2012. ,
MRI pattern in asymptomatic natalizumabassociated PML, J Neurol Neurosurg Psychiatry, vol.86, pp.793-801, 2015. ,
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases, Lancet Neurol, vol.9, pp.438-484, 2010. ,
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient, Bone Marrow Transplant, vol.46, pp.987-92, 2011. ,
Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2, Neurology, vol.65, p.1510, 2005. ,
Treatment of progressive multifocal leukoencephalopathy with interleukin 7, JAMA Neurol, vol.71, pp.1030-1035, 2014. ,
Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy, Open Forum Infect Dis, vol.1, p.74, 2014. ,
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives, Ther Adv Neurol Disord, vol.8, pp.255-73, 2015. ,